Skip to main content
bioRxiv
  • Home
  • About
  • Submit
  • ALERTS / RSS
Advanced Search
New Results

TGFβ signalling is required to maintain pluripotency of human naïve pluripotent stem cells

View ORCID ProfileAnna Osnato, Stephanie Brown, View ORCID ProfileChristel Krueger, View ORCID ProfileSimon Andrews, View ORCID ProfileAmanda J. Collier, Shota Nakanoh, Mariana Quiroga Londoño, View ORCID ProfileBrandon T. Wesley, Daniele Muraro, Sophie Brumm, View ORCID ProfileKathy Niakan, View ORCID ProfileLudovic Vallier, Daniel Ortmann, View ORCID ProfilePeter J. Rugg-Gunn
doi: https://doi.org/10.1101/2021.07.10.451887
Anna Osnato
1Wellcome–MRC Cambridge Stem Cell Institute, Jeffrey Cheah Biomedical Centre, University of Cambridge, Cambridge, CB2 0AW, UK
2Department of Surgery, University of Cambridge, Cambridge, CB2 0SZ, UK
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Anna Osnato
Stephanie Brown
1Wellcome–MRC Cambridge Stem Cell Institute, Jeffrey Cheah Biomedical Centre, University of Cambridge, Cambridge, CB2 0AW, UK
2Department of Surgery, University of Cambridge, Cambridge, CB2 0SZ, UK
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Christel Krueger
3Bioinformatics Group, The Babraham Institute, Cambridge, CB22 3AT, UK
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Christel Krueger
Simon Andrews
3Bioinformatics Group, The Babraham Institute, Cambridge, CB22 3AT, UK
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Simon Andrews
Amanda J. Collier
4Epigenetics Programme, The Babraham Institute, Cambridge, CB22 3AT, UK
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Amanda J. Collier
Shota Nakanoh
1Wellcome–MRC Cambridge Stem Cell Institute, Jeffrey Cheah Biomedical Centre, University of Cambridge, Cambridge, CB2 0AW, UK
2Department of Surgery, University of Cambridge, Cambridge, CB2 0SZ, UK
5Division of Embryology, National Institute for Basic Biology, Okazaki 444-8787, Japan
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Mariana Quiroga Londoño
1Wellcome–MRC Cambridge Stem Cell Institute, Jeffrey Cheah Biomedical Centre, University of Cambridge, Cambridge, CB2 0AW, UK
2Department of Surgery, University of Cambridge, Cambridge, CB2 0SZ, UK
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Brandon T. Wesley
1Wellcome–MRC Cambridge Stem Cell Institute, Jeffrey Cheah Biomedical Centre, University of Cambridge, Cambridge, CB2 0AW, UK
2Department of Surgery, University of Cambridge, Cambridge, CB2 0SZ, UK
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Brandon T. Wesley
Daniele Muraro
1Wellcome–MRC Cambridge Stem Cell Institute, Jeffrey Cheah Biomedical Centre, University of Cambridge, Cambridge, CB2 0AW, UK
2Department of Surgery, University of Cambridge, Cambridge, CB2 0SZ, UK
6Wellcome Sanger Institute, Hinxton, Cambridge, CB10 1SA, UK
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Sophie Brumm
7Human Embryo and Stem Cell Laboratory, The Francis Crick Institute, London, NW1 1AT, UK
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Kathy Niakan
7Human Embryo and Stem Cell Laboratory, The Francis Crick Institute, London, NW1 1AT, UK
8Centre for Trophoblast Research, University of Cambridge, Cambridge, CB2 3EG, UK
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Kathy Niakan
Ludovic Vallier
1Wellcome–MRC Cambridge Stem Cell Institute, Jeffrey Cheah Biomedical Centre, University of Cambridge, Cambridge, CB2 0AW, UK
2Department of Surgery, University of Cambridge, Cambridge, CB2 0SZ, UK
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Ludovic Vallier
Daniel Ortmann
1Wellcome–MRC Cambridge Stem Cell Institute, Jeffrey Cheah Biomedical Centre, University of Cambridge, Cambridge, CB2 0AW, UK
2Department of Surgery, University of Cambridge, Cambridge, CB2 0SZ, UK
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Peter J. Rugg-Gunn
1Wellcome–MRC Cambridge Stem Cell Institute, Jeffrey Cheah Biomedical Centre, University of Cambridge, Cambridge, CB2 0AW, UK
4Epigenetics Programme, The Babraham Institute, Cambridge, CB22 3AT, UK
8Centre for Trophoblast Research, University of Cambridge, Cambridge, CB2 3EG, UK
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Peter J. Rugg-Gunn
  • For correspondence: peter.rugg-gunn@babraham.ac.uk
  • Abstract
  • Full Text
  • Info/History
  • Metrics
  • Supplementary material
  • Preview PDF
Loading

Abstract

The signalling pathways that maintain primed human pluripotent stem cells (hPSCs) have been well characterised, revealing a critical role for TGFβ/Activin/Nodal signalling. In contrast, the signalling requirements of naïve human pluripotency have not been fully established. Here, we demonstrate that TGFβ signalling is required to maintain naïve hPSCs. The downstream effector proteins – SMAD2/3 – bind common sites in naïve and primed hPSCs, including shared pluripotency genes. In naïve hPSCs, SMAD2/3 additionally bind to active regulatory regions near to naïve pluripotency genes. Inhibiting TGFβ signalling in naïve hPSCs causes the downregulation of SMAD2/3-target genes and pluripotency exit. Single-cell analyses reveal that naïve and primed hPSCs follow different transcriptional trajectories after inhibition of TGFβ signalling. Primed hPSCs differentiate into neuroectoderm cells, whereas naïve hPSCs transition into trophectoderm. These results establish that there is a continuum for TGFβ pathway function in human pluripotency spanning a developmental window from naïve to primed states.

Competing Interest Statement

The authors have declared no competing interest.

Copyright 
The copyright holder for this preprint is the author/funder, who has granted bioRxiv a license to display the preprint in perpetuity. It is made available under a CC-BY-NC-ND 4.0 International license.
Back to top
PreviousNext
Posted July 11, 2021.
Download PDF

Supplementary Material

Email

Thank you for your interest in spreading the word about bioRxiv.

NOTE: Your email address is requested solely to identify you as the sender of this article.

Enter multiple addresses on separate lines or separate them with commas.
TGFβ signalling is required to maintain pluripotency of human naïve pluripotent stem cells
(Your Name) has forwarded a page to you from bioRxiv
(Your Name) thought you would like to see this page from the bioRxiv website.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Share
TGFβ signalling is required to maintain pluripotency of human naïve pluripotent stem cells
Anna Osnato, Stephanie Brown, Christel Krueger, Simon Andrews, Amanda J. Collier, Shota Nakanoh, Mariana Quiroga Londoño, Brandon T. Wesley, Daniele Muraro, Sophie Brumm, Kathy Niakan, Ludovic Vallier, Daniel Ortmann, Peter J. Rugg-Gunn
bioRxiv 2021.07.10.451887; doi: https://doi.org/10.1101/2021.07.10.451887
Digg logo Reddit logo Twitter logo Facebook logo Google logo LinkedIn logo Mendeley logo
Citation Tools
TGFβ signalling is required to maintain pluripotency of human naïve pluripotent stem cells
Anna Osnato, Stephanie Brown, Christel Krueger, Simon Andrews, Amanda J. Collier, Shota Nakanoh, Mariana Quiroga Londoño, Brandon T. Wesley, Daniele Muraro, Sophie Brumm, Kathy Niakan, Ludovic Vallier, Daniel Ortmann, Peter J. Rugg-Gunn
bioRxiv 2021.07.10.451887; doi: https://doi.org/10.1101/2021.07.10.451887

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
  • Tweet Widget
  • Facebook Like
  • Google Plus One

Subject Area

  • Cell Biology
Subject Areas
All Articles
  • Animal Behavior and Cognition (3586)
  • Biochemistry (7545)
  • Bioengineering (5495)
  • Bioinformatics (20732)
  • Biophysics (10294)
  • Cancer Biology (7951)
  • Cell Biology (11610)
  • Clinical Trials (138)
  • Developmental Biology (6586)
  • Ecology (10168)
  • Epidemiology (2065)
  • Evolutionary Biology (13580)
  • Genetics (9521)
  • Genomics (12817)
  • Immunology (7906)
  • Microbiology (19503)
  • Molecular Biology (7641)
  • Neuroscience (41982)
  • Paleontology (307)
  • Pathology (1254)
  • Pharmacology and Toxicology (2192)
  • Physiology (3259)
  • Plant Biology (7025)
  • Scientific Communication and Education (1294)
  • Synthetic Biology (1947)
  • Systems Biology (5419)
  • Zoology (1113)